Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enarodustat tablets for chemotherapy-induced anemia in patients with non-myeloid malignancies
CTR20243024Phase 2Active
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of enarodustat in chemotherapy-induced anaemia (CIA), sponsored by Shenzhen Salubris Pharmaceuticals Co., Ltd.. Started Sep 2024; status: active.
02
Drugs
enarodustat
03
Conditions
chemotherapy-induced anaemia (CIA)
Beyond the preview
Go deeper on CTR20243024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243024.